{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:52:41Z","timestamp":1782928361153,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ygyno.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T21:01:37Z","timestamp":1771448497000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pre-operative cross-sectional imaging of chest, abdomen, pelvis is not cost-effective for low-grade endometrial cancer"],"prefix":"10.1016","volume":"206","author":[{"given":"Isabel","family":"Beshar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Khorshid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahana","family":"Somasegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u2019Or\u00e9al","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Blemur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Tostrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ygyno.2026.02.001_bb0005","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/cancers17061035","article-title":"Trends in endometrial Cancer incidence among premenopausal and postmenopausal women in the United States between 2001 and 2021","volume":"17","author":"Guo","year":"2025","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.ygyno.2026.02.001_bb0010","doi-asserted-by":"crossref","first-page":"S472","DOI":"10.1016\/j.jacr.2020.09.001","article-title":"ACR appropriateness criteria\u00ae Pretreatment evaluation and follow-up of endometrial Cancer","volume":"17","author":"Reinhold","year":"2020","journal-title":"J. Am. Coll. Radiol."},{"issue":"9","key":"10.1016\/j.ygyno.2026.02.001_bb0015","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.3390\/curroncol30090597","article-title":"Diagnostic performance of preoperative imaging in endometrial Cancer","volume":"30","author":"Hashimoto","year":"2023","journal-title":"Curr. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.001_bb0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","article-title":"Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Koh","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"8","key":"10.1016\/j.ygyno.2026.02.001_bb0025","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/IGC.0000000000001076","article-title":"Clinical utility of preoperative computed tomography in patients with endometrial Cancer","volume":"27","author":"Bogani","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"S2","key":"10.1016\/j.ygyno.2026.02.001_bb0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ijgo.12618","article-title":"Role of imaging in the routine management of endometrial cancer","volume":"143","author":"Lin","year":"2018","journal-title":"Int. J. Gynecol. Obst."},{"key":"10.1016\/j.ygyno.2026.02.001_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejogrb.2021.01.052","article-title":"Initial experience with positron emission tomography\/computed tomography in addition to computed tomography and magnetic resonance imaging in preoperative risk assessment of endometrial cancer patients","volume":"259","author":"Nordskar","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2026.02.001_bb0040","article-title":"Utility of computerized tomography in clinical staging and surgical decision making in patients with uterine cancer","volume":"60","author":"Tannous","year":"2025","journal-title":"Gynecol. Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.001_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2021.02.021","article-title":"The use of imaging in endometrial cancer prior to potential surgery: are guidelines being followed?","volume":"161","author":"Schnarr","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.001_bb0050","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2008.08.001","article-title":"The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies","volume":"111","author":"Bansal","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.001_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ygyno.2025.07.011","article-title":"Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019","volume":"200","author":"Clarke","year":"2025","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.02.001_bb0060","doi-asserted-by":"crossref","first-page":"268.e1","DOI":"10.1016\/j.ajog.2016.11.1050","article-title":"Survival implications of time to surgical treatment of endometrial cancers","volume":"216","author":"Shalowitz","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"13","key":"10.1016\/j.ygyno.2026.02.001_bb0065","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3390\/cancers17132076","article-title":"The impact of treatment delay on endometrial and ovarian cancer patients: a systematic review","volume":"17","author":"Zouzoulas","year":"2025","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ygyno.2026.02.001_bb0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/02841868909092276","article-title":"Contribution of vaginal scanning to sonographic evaluation of endometrial Cancer invasion","volume":"28","author":"Cacciatore","year":"1989","journal-title":"Acta Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.02.001_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1053\/j.sult.2019.04.001","article-title":"Imaging and staging of endometrial cancer","volume":"40","author":"Faria","year":"2019","journal-title":"Semin. Ultrasound CT MRI"},{"issue":"3","key":"10.1016\/j.ygyno.2026.02.001_bb0080","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.mric.2017.03.010","article-title":"From staging to prognostication","volume":"25","author":"Nougaret","year":"2017","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.001_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14737140.2015.992420","article-title":"Identifying aggressive forms of endometrioid-type endometrial cancer: new insights into molecular subtyping","volume":"15","author":"Liu","year":"2015","journal-title":"Expert. Rev. Anticancer. Ther."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.001_bb0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/cancers17010038","article-title":"Abnormal p53 high-grade endometrioid endometrial cancer: a systematic review and meta-analysis","volume":"17","author":"Casanova","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.001_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(25)00612-6","article-title":"Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial","volume":"27","author":"Van Den Heerik","year":"2026","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2026.02.001_bb0100","series-title":"National Chest CT Scan Procedure Pricing Summary","year":"2025"},{"key":"10.1016\/j.ygyno.2026.02.001_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/973830","article-title":"Are costs of robot-assisted surgery warranted for gynecological procedures?","volume":"2011","author":"Van Dam","year":"2011","journal-title":"Obstet. Gynecol. Int."},{"key":"10.1016\/j.ygyno.2026.02.001_bb0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ygyno.2024.10.021","article-title":"Cost-effectiveness of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a US payer perspective","volume":"192","author":"Coleman","year":"2025","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.02.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.0033","article-title":"Cost-effectiveness of pembrolizumab with chemoradiotherapy for locally advanced cervical cancer","volume":"8","author":"Courtney","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2026.02.001_bb0120","article-title":"Cost effectiveness of immunotherapy combination therapies for endometrial cancer","volume":"52","author":"Benjamin","year":"2024","journal-title":"Gynecol. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.001_bb0125","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2025.36.e6","article-title":"Immunotherapy plus chemotherapy in patients with advanced endometrial cancer: a cost-effectiveness analysis","volume":"36","author":"Zhu","year":"2025","journal-title":"J. Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.001_bb0130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2017.12.015","article-title":"Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase","volume":"148","author":"Tran","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.001_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ygyno.2021.05.038","article-title":"Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: a Markov analysis","volume":"162","author":"Ackroyd","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2026.02.001_bb0140","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1136\/ijgc-2024-005296","article-title":"Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysis","volume":"34","author":"Zhu","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.001_bb0145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/13696998.2021.1917140","article-title":"Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer","volume":"24","author":"Thurgar","year":"2021","journal-title":"J. Med. Econ."},{"issue":"3","key":"10.1016\/j.ygyno.2026.02.001_bb0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ygyno.2016.09.005","article-title":"Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: an NRG oncology\/Gynecologic oncology group study","volume":"143","author":"Rose","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.001_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/807205","article-title":"Grade 1 endometrioid endometrial carcinoma presenting with pelvic bone metastasis: a case report and review of the literature","volume":"2013","author":"Nguyen","year":"2013","journal-title":"Case Rep. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.001_bb0160","doi-asserted-by":"crossref","first-page":"216.e1","DOI":"10.1016\/j.ajog.2007.08.028","article-title":"Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer","volume":"198","author":"Chan","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ygyno.2026.02.001_bb0165","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/IGC.0b013e31821872f4","article-title":"Defining prognostic variables in recurrent endometrioid endometrial cancer","volume":"21","author":"Esselen","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.001_bb0170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygyno.2005.06.010","article-title":"Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors","volume":"99","author":"Eltabbakh","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2026.02.001_bb0175","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/bjs.10561","article-title":"Minimally invasive surgery and its impact on 30-day postoperative complications, unplanned readmissions and mortality","volume":"104","author":"Sood","year":"2017","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ygyno.2026.02.001_bb0180","year":"2026","journal-title":"Biol. Insights"},{"key":"10.1016\/j.ygyno.2026.02.001_bb0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5114\/wiitm.2021.108800","article-title":"Complications in laparoscopic and robotic-assisted surgery: definitions, classifications, incidence and risk factors - an up-to-date review","author":"Watrowski","year":"2021","journal-title":"Videosurg. Other Miniinvas. Techn."},{"issue":"2","key":"10.1016\/j.ygyno.2026.02.001_bb0190","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2021.32.e22","article-title":"Recurrence risk factors in stage IA grade 1 endometrial cancer","volume":"32","author":"Nwachukwu","year":"2021","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.001_bb0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2022.11.012","article-title":"Recurrence and survival in endometrioid endometrial cancer - a population-based cohort study","volume":"168","author":"\u00c5kesson","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.02.001_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejogrb.2025.113958","article-title":"Upfront and interval debulking surgery in advanced\/metastatic endometrial cancer in the era of molecular classification","volume":"310","author":"Caiazzo","year":"2025","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"10.1016\/j.ygyno.2026.02.001_bb0205","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2011.05.020","article-title":"Surgical cytoreduction in stage IV endometrioid endometrial carcinoma","volume":"122","author":"Shih","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.02.001_bb0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s44276-024-00084-4","article-title":"Survival benefit of cytoreductive surgery in patients with primary stage IV endometrial cancer: a systematic review & meta-analysis","volume":"2","author":"Pham","year":"2024","journal-title":"BJC Rep."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582600781X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582600781X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:20:54Z","timestamp":1782926454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582600781X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"alternative-id":["S009082582600781X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.02.001","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-operative cross-sectional imaging of chest, abdomen, pelvis is not cost-effective for low-grade endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}